Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

Table 4 Analysis of factors associated with malaria in pregnancy by rapid diagnostic test among delivering women

Variable	MIP by RDT		Crude OR	P-value	Adjusted OR	P-value
	N	No. RDT-positive (%)	(95% CI)		(95% CI)
Maternal age
<20 years	97	27 (27.84)	1.87 (1.11, 3.18)	0.020	1.05 (0.54, 2.05)	0.888
≥20 years	334	57 (17.07)	Reference		Reference
Health facility
Geita hospital	265	36 (13.58)	Reference		Reference
Katoro HC	166	48 (28.92)	2.59 (1.59, 4.21)	<0.001	2.86 (1.69, 4.86)	<0.001
Gravidity
Paucigravidae	227	56 (24.67)	2.06 (1.25, 3.39)	0.005	2.37 (1.29, 4.38)	0.006
Multigravidae	204	28 (13.73)	Reference		Reference
Level of education
None/Primary	360	80 (22.22)	4.79 (1.69, 13.53)	0.003	3.51 (1.19, 10.39)	0.023
Secondary/Higher	71	4 (5.63)	Reference		Reference
Occupation
Peasant/livestock	370	79 (21.35)	3.04 (1.18, 7.85)	0.021	1.86 (0.68, 5.10)	0.230
Employed/Business	61	5 (8.20)	Reference		Reference
Bed net use
No	10	4 (40.00)	Reference		Reference
Yes	403	77 (19.11)	0.35 (0.10, 1.28)	0.115	0.28 (0.07, 1.10)	0.067
SP receipt
<3 doses	405	84 (20.74)	-	-	-	-
≥3 doses	26	0 (0.00)

HC = health centre; RDT = rapid diagnostic test, MIP = malaria in pregnancy, OR = odds ratio, 95% CI = 95% confidence interval, SP = sulphadoxine-pyrimethamine; Significant p-values are presented in bold.

ISSN: 1475-2875